CMR becomes the third surgical robotics company alongside Intuitive Surgical and SHURUI Robotics to obtain a CE mark in Europe for paediatric treatment.

CMR plans to begin US commercial activities for its Versius robots in 2026. Image credit: T. Schneider via Shutterstock.com. CMR Surgical has secured US Food and Drug Administration (FDA) clearance ...

CMR Surgical announced today that it received CE mark and UK approval for its Versius surgical robot in pediatric surgery.

Small, modular design of the Versius system supports use in robotic-assisted paediatric surgery Cambridge, UK – 8 January 2026, CMR Surgical (‘CMR’ or ‘the Company’), the global surgical robotics ...

CMR Surgical received the approval for abdominal surgery for its Versius platform in patients under age 18 in Europe, while SS Innovations will incorporate five new instruments into its SSi Mantra ...

CAMBRIDGE, UK – 27th March 2023, 07:00 (BST). CMR Surgical (CMR) – the global surgical robotics business – today announces that its next-generation surgical robotic system, Versius ®, has been used to ...

insights from industryMark SlackChief Medical OfficerCMR Surgical In this interview, we speak to Mark Slack, Chief Medical Officer at CMR Surgical, about their next-generation surgical robot Versius ...